Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.
CONCLUSION: Our DA to allow patients to make an informed decision with their physician regarding dabigatran versus warfarin in AF, proved understandable, comprehensive and helpful.
PMID: 24163147 [PubMed - indexed for MEDLINE]
Source: Journal of Population Therapeutics and Clinical Pharmacology - Category: Drugs & Pharmacology Tags: J Popul Ther Clin Pharmacol Source Type: research
More News: Atrial Fibrillation | Clinical Trials | Coumadin | Drugs & Pharmacology | Hemorrhagic Stroke | HIV AIDS | Pradaxa | Sports Medicine | Stroke | Warfarin